scholarly article | Q13442814 |
P2093 | author name string | Akbar K Waljee | |
Ji Zhu | |||
Peter D R Higgins | |||
Ryan W Stidham | |||
Boang Liu | |||
Shirley Cohen-Mekelburg | |||
Kay Sauder | |||
Beth I Wallace | |||
Yumu Liu | |||
P2860 | cites work | Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease | Q30054715 |
C-reactive protein as a marker for inflammatory bowel disease | Q35912315 | ||
Assessing response and loss of response to biological therapies in IBD. | Q37856191 | ||
C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis | Q38474301 | ||
Emerging biologics in inflammatory bowel disease | Q39004625 | ||
Utility of Biomarkers in the Management of Inflammatory Bowel Disease | Q39110763 | ||
Incidence and Prevalence of Crohn's Disease and Ulcerative Colitis in Olmsted County, Minnesota From 1970 Through 2010. | Q40471255 | ||
Role for therapeutic drug monitoring during induction therapy with TNF antagonists in IBD: evolution in the definition and management of primary nonresponse | Q43988900 | ||
Predicting corticosteroid-free endoscopic remission with vedolizumab in ulcerative colitis | Q47557672 | ||
Pharmacokinetics and Exposure Response Relationships of Ustekinumab in Patients with Crohn's Disease | Q50057782 | ||
Biological therapies in inflammatory bowel disease: Beyond anti-TNF therapies. | Q52653377 | ||
C-reactive protein, an indicator for maintained response or remission to infliximab in patients with Crohn's disease: a post-hoc analysis from ACCENT I | Q83260276 | ||
Levels of drug and antidrug antibodies are associated with outcome of interventions after loss of response to infliximab or adalimumab | Q87453129 | ||
Predicting Corticosteroid-Free Biologic Remission with Vedolizumab in Crohn's Disease | Q88398451 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | machine learning | Q2539 |
P304 | page(s) | e193721 | |
P577 | publication date | 2019-05-03 | |
P1476 | title | Development and Validation of Machine Learning Models in Prediction of Remission in Patients With Moderate to Severe Crohn Disease | |
P478 | volume | 2 |
Q93101225 | Error in End Matter Disclaimer |
Q100504047 | The four epidemiological stages in the global evolution of inflammatory bowel disease |
Search more.